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Abstract
Interferon-inducible GTPases of the Immunity Related GTPase (IRG) and Guanylate Binding Protein (GBP) families provide
resistance to intracellular pathogenic microbes. IRGs and GBPs stably associate with pathogen-containing vacuoles (PVs)
and elicit immune pathways directed at the targeted vacuoles. Targeting of Interferon-inducible GTPases to PVs requires the
formation of higher-order protein oligomers, a process negatively regulated by a subclass of IRG proteins called IRGMs. We
found that the paralogous IRGM proteins Irgm1 and Irgm3 fail to robustly associate with ‘‘non-self’’ PVs containing either
the bacterial pathogen Chlamydia trachomatis or the protozoan pathogen Toxoplasma gondii. Instead, Irgm1 and Irgm3
reside on ‘‘self’’ organelles including lipid droplets (LDs). Whereas IRGM-positive LDs are guarded against the stable
association with other IRGs and GBPs, we demonstrate that IRGM-stripped LDs become high affinity binding substrates for
IRG and GBP proteins. These data reveal that intracellular immune recognition of organelle-like structures by IRG and GBP
proteins is partly dictated by the missing of ‘‘self’’ IRGM proteins from these structures.
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Introduction
Many intracellular pathogens including the bacterium C.
trachomatis and the protozoa T. gondii co-opt the host cell
endomembrane system to enclose themselves inside membrane-
bound vacuoles. Within the confines of these remodeled PVs,
microbes acquire nutrients and replicate [1]. To combat these
pathogens, the mammalian host has evolved a large repertoire of
cell-autonomous defense mechanisms that kill or restrain the
replication of microbes residing within vacuoles [2,3]. While these
defense mechanisms are effective at targeting foreign or ‘‘non-self’’
vacuoles, they also have the potential to cause organelle damage
and must therefore be tightly regulated. Control over these host
defenses is executed at two critical steps: (i) induction of genes
encoding host resistance factors in the context of an infection and
(ii) targeting of these resistance factors to the appropriate
intracellular location, for example to PVs.
These two modes of regulation are exemplified by the induction
and execution of cell-autonomous defenses by the cytokine
Interferon-c (IFNc). The importance of IFNc in host immunity
is demonstrated by the severe immuno-deficiencies observed in
genetically engineered mouse strains lacking IFNc or its receptor
and in patients carrying rare mutations in genes critical for IFNc
signal transduction [4,5]. IFNc is produced by immune-activated
lymphocytes and exerts its antimicrobial effects by dramatically
remodeling the transcriptional expression profile of target cells
bearing the IFNc receptor [3]. IFNc-induced resistance genes
include members of two IFN-inducible GTPase families named
IRGs and GBPs. Members of both GTPase families have the
ability to translocate and to adhere specifically to PVs in order to
inhibit intracellular pathogen growth. Although the specificity of
this intracellular targeting event is well documented [3,6], the
underlying mechanism is unclear.
Once docked to PVs, GBP proteins recruit antimicrobial protein
complexes that include the NADPH oxidase NOX2, the autophagy
apparatus and the inflammasome [3]. IRG proteins on the other
hand can directly disrupt PV membranes, thereby releasing
vacuolar pathogens into the cytosol where they can be removed
through autophagy [6,7]. IRG GTPases are divided into two
categories: (i) the predominantly cytosolic GKS proteins constitute
the most abundant group and harbor a conserved GX4GKS
sequence in the first nucleotide-binding motif (G1), (ii) the
predominantly membrane-bound IRGM proteins instead contain
a non-canonical P-loop sequence GX4GMS [6]. Both GKS and
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IRGM proteins are essential for cell-autonomous resistance to
infections with C. trachomatis and T. gondii in mice but fulfill distinct
functions in this process [6]. Whereas GKS proteins directly target
and eliminate C. trachomatis and T. gondii PVs, IRGM proteins
appear to orchestrate the targeting of GKS proteins to PVs by an
incompletely understood mechanism [6]. In addition to their role as
regulators of GKS protein function, IRGM proteins also exert
antimicrobial activities independently of GKS proteins. Both mouse
and human IRGM proteins promote the formation of autophago-
somes upon IFNc stimulation [8–10]. Additionally, murine Irgm1
loads onto early phagosomes containing beads or live bacteria [11–
13]. Vacuolar Irgm1 interacts with target SNARE protein
complexes and through these interactions can facilitate the rapid
fusion of Irgm1-coated phagosomes with degradative lysosomes.
Accelerated lysosomal maturation was shown to result in the
destruction of the attenuated pathogen Mycobacterium bovis BCG
contained within Irgm1-positive phagosomes in mouse macrophag-
es [13]. Similar to Irgm1, Irgm3 was implicated as a mediator of
direct antimicrobial activities towards T. gondii [14].
To initially establish vacuoles permissive for microbial survival
in IFNc-activated cells, pathogens must have evolved strategies to
evade the direct, fast-acting immune responses mediated by
membrane-bound Irgm1 and Irgm3 proteins. In agreement with
the existence of such evasion mechanisms, we observed that Irgm1
and Irgm3 failed to robustly associate with PVs formed by either
C. trachomatis or T. gondii. The absence of substantial amounts of
Irgm1/m3 from PVs contrasted with the abundant localization of
Irgm1/m3 to ‘‘self’’ structures like LDs. We found that Irgm1/m3-
decorated LDs are largely devoid of GKS and GBP proteins,
whereas Irgm1/m3-deficient PVs are targets for GKS and GBP
proteins. These observations led us to hypothesize that the absence
of Irgm1/m3 proteins marked intracellular structures as targets for
a ‘‘second line of defense’’ mediated by GKS and GBP proteins. In
support of this hypothesis, we demonstrated that stripping LDs of
Irgm1/3 resulted in mistargeting of GKS and GBP proteins to
LDs independently of an infection. Because IRGM proteins were
previously shown to inhibit GKS protein oligomerization [15], we
propose a model in which the missing of ‘‘self’’ IRGM proteins from
‘‘non-self’’ PVs results in the formation of GKS (and GBP) protein
oligomers with high avidity for membrane binding.
Results
Protein oligomerization is necessary and sufficient to
target Irgb10 to C. trachomatis inclusions
GKS proteins in their GTP-bound state form dimers [6].
Dimerization occurs at the G domain interface and is a
prerequisite for the formation of higher order GKS protein
oligomers. Mutations that diminish guanine nucleotide binding or
disrupt the G domain interface eliminate both protein oligomer-
ization and targeting to T. gondii PVs [16,17]. To determine if
these findings extended to other PVs, we first tested whether
guanine nucleotide binding of the GKS protein Irgb10 was
essential for their targeting to ‘‘inclusions,’’ the PVs formed by C.
trachomatis. We replaced the serine on position 82 of Irgb10 in the
conserved P-loop GKS motif with asparagine (Irgb10S82N). This
mutation is analogous to the Irga6S83N mutation that abrogates
guanine nucleotide binding and T. gondii PV localization [16]. We
found that Irgb10-GFP-fusion proteins harboring the S82N
mutation or a deletion of the central G-domain (Irgb10DG) failed
to localize to C. trachomatis inclusions in infected mouse embryonic
fibroblasts (MEFs) (Figure 1A).
Combined with previous results in T. gondii [16], our data
suggested that protein oligomerization of GTP-bound Irgb10 is
essential for tethering this GKS protein to C. trachomatis inclusion
membranes. To test whether protein oligomerization of the N- and
C-terminal domains of Irgb10 was sufficient to target inclusion
membranes, we replaced the G domain of Irgb10 with alternative
protein oligomerization domains and monitored the subcellular
localization of these protein chimeras. We first substituted the G
domain of Irgb10 with the tetramer-forming protein dsRED [18],
which emits red fluorescence exclusively in the oligomerized form
[19]. Insertion of dsRED between the N-terminal domain (NTD)
and C-terminal domain (CTD) of Irgb10DG (Irgb10NTD-dsRED-CTD)
restored the association of a GFP-tagged fusion protein with C.
trachomatis inclusions (Figure 1A). Inserting dsRED in between the N-
terminal myristoylation motif (Myr) and the CTD of Irgb10
(Irgb10Myr-dsRED-CTD) similarly redirected the mutant variant
Irgb10Myr-CTD to inclusions (Figure 1A). Tetramerized Irgb10
localized to IncG-positive inclusion membranes (Figure 1B). Inclu-
sion targeting required the presence of both the Irgb10 myristoyla-
tion motif and the C-terminal amphipathic helix aK (Figure 1A,
Figure 2A and data not shown). As an alternative mediator of
protein oligomerization, we used the highly oligomeric cyto-
plasmic yeast protein TyA [20]. Insertion of TyA in between
the myristoylation domain and the C-terminus of Irgb10
(Irgb10Myr-TyA-CTD) similarly re-localized these fusion proteins
towards inclusions. Myristoylated-TyA (Myr-TyA) localized to
microvesicles, as described [21], but failed to associate with
inclusions (Figure 1C), demonstrating that the C-terminus of Irgb10
containing the aK amphipathic helix is essential for inclusion
targeting. In summary, these data show that the oligomerization of
the N- and C-terminal lipid binding domains of Irgb10 was sufficient
to drive localization to inclusions.
Tetramerized Irgb10 targets inclusions independently of
Irgm3
The targeting of GKS proteins to T. gondii is substantially
diminished in the absence of the IRGM proteins Irgm1 and Irgm3
[16,22]. We found that the association of Irgb10 and other GKS
proteins with C. trachomatis inclusions was similarly reduced in
infectedMEFs derived from Irgm12/2, Irgm32/2 and Irgm1/m32/2
mice (Figure 3). These data indicate that Irgm1 and Irgm3 either
directly or indirectly promote the delivery of GKS proteins to
inclusions. Because IRGM proteins physically interact with GKS
Author Summary
Cell-autonomous host defense pathways directed against
vacuolar pathogens constitute an essential arm of the
mammalian innate immune defense system. Underlying
most of these defense strategies is the ability of the host
cell to recognize foreign or pathogen-modified structures
and to deliver antimicrobial molecules specifically to these
sites. Specific targeting of molecules to pathogen-contain-
ing vacuoles (PVs) requires host cells to recognize PVs as
‘‘non-self’’ structures that are distinct from intact ‘‘self’’
structures like organelles and other endomembrane
components. In this work, we develop a new framework
for understanding a critical principle that guides the
mammalian immune system in the recognition of PVs as
‘‘non-self’’ structures. Our data indicates that so-called
IRGM proteins function as markers of ‘‘self’’ compartments.
We find that IRGM proteins act as ‘‘guards’’ that prevent a
set of antimicrobial GTPases from stable association with
‘‘self’’ membranes. Because IRGM proteins are largely
absent from ‘‘non-self’’ PVs, we propose that intracellular
immune recognition of PVs can occur via the missing of
‘‘self’’ IRGM proteins.
IRGM Proteins Guard Endomembranes
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Figure 1. Oligomerization of the N- and C-terminus of Irgb10 is sufficient to target GFP-fusion proteins to C. trachomatis inclusions.
(A and C) The indicated GFP fusion proteins were ectopically expressed in wildtype MEFs. Transfected cells were then infected with C. trachomatis
and treated with IFNc at 3 hpi. Cells were fixed and stained for DNA with Hoechst at 20 hpi. Arrows point at Hoechst-positive inclusions. (B) Cells were
transfected with NTD-dsRED-CTD lacking a GFP moitety, infected with C. trachomatis and stained with anti-IncG.
doi:10.1371/journal.ppat.1003414.g001
Figure 2. Tetramerized Irgb10 targets inclusions independently of Irgm3. (A) Wildtype and Irgm32/2 MEFs were transfected with
Irgb10NTD-dsRED-CTD or Irgb10NTD-dsRED-aK, subsequently infected with C. trachomatis and treated with IFNc at 3 hpi. Fixed cells were stained with anti-C.
trachomatis and Hoechst. The frequency at which dsRED fusions proteins co-locliazed with incluions inside transfected cells at 20 hpi was quantified
in three independent experiments. Representative data from one experiment and images at 20 hpi are shown. Graph represents average values 6
SD. (B) Wildtype MEFs were infected with C. trachomatis, treated with IFNc at 3 hpi and the frequency of endogenous Irgb10 localizing to inclusions
at 20 hpi was quantified. Error bars represent standard deviations. n.s. = not significant; **, p,0.01.
doi:10.1371/journal.ppat.1003414.g002
IRGM Proteins Guard Endomembranes
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proteins at the G domain interface [16], we hypothesized that
IRGM proteins facilitate the delivery of GKS proteins to
inclusions through their interactions with the G domain of GKS
proteins. In such a scenario, artificially oligomerized Irgb10
lacking a G domain should target inclusions independently of
IRGM proteins. To test the hypothesis, we expressed two
tetramerized, chimeric Irgb10DG proteins, Irgb10NTD-dsRED-CTD
and Irgb10NTD-dsRED-aK, in wildtype and Irgm32/2 MEFs and
scored the frequency of dsRED signal on inclusions. We chose
Irgm32/2MEFs for these experiments, because they displayed the
most pronounced defect in targeting endogenous Irgb10 to
inclusions (Figure 3). In contrast to endogenous Irgb10
(Figure 2B and Figure 3), tetramerized Irgb10 lacking a G domain
targeted inclusions with the same efficiency in wildtype and Irgm3-
deficient cells (Figure 2A). These data suggest that Irgm3 regulates
the targeting of Irgb10 to inclusions through its interaction with
the G domain of Irgb10.
Irgm1 and Irgm3 strongly associate with LDs but not PVs
It is currently unknown where inside a cell IRGM proteins
interact with GKS proteins to regulate their function. To
determine whether IRGM proteins regulate GKS proteins directly
at PV membranes, we first monitored the subcellular localization
of IRGM proteins in cells infected with either T. gondii or C.
trachomatis. As reported previously [14,23], we found that
endogenous Irgm3 but not Irgm1 associated with T. gondii PVs,
albeit only weakly relative to its association with endogenous,
puncta-like structures (Figure 4A and data not shown). These
results are also in agreement with a previous report demonstrating
that Irgm3 associates with T. gondii PVs at a lower frequency than
GKS proteins do [24]. Next we examined the subcellular
localization of endogenous Irgm1 and Irgm3 in C. trachomatis-
infected cells. In agreement with a previous report [25], we
detected association of Irgm3 with C. trachomatis inclusions at 2 hpi.
However, Irgm3 associated only weakly with inclusions relative to
its interactions with endogenous structures (Figure 4B). Similar to
the staining pattern of T. gondii PVs, we failed to detect the
presence of Irgm1 on inclusions (data not shown). To determine
whether Irgm1 or Irgm3 could target established inclusions, we
infected MEFs with C. trachomatis and subsequently treated cells
with IFNc at 3hpi. Under these experimental conditions
endogenous as well as ectopically expressed Irgm1 and Irgm3
were not present at inclusion membranes in detectable amounts at
20 hpi (Figure 4C, Figure 5B and data not shown). Collectively,
these data show that PVs formed by either C. trachomatis or T. gondii
are devoid of substantial amounts of Irgm1 and Irgm3 proteins.
Because established PVs lack sizeable amounts of Irgm1/m3,
we considered the hypothesis that IRGM proteins regulate Irgb10
and other GKS proteins at sites distinct from PVs. It is known that
IRGM proteins localize to various endomembranes, including
LDs, a neutral lipid storage organelle [6]. Specifically, Irgm3 was
shown to localize to LDs in IFNc-treated dendritic cells [26]. To
determine whether or not Irgm3 also localizes to LDs in IFNc-
treated MEFs, we induced the formation of LDs by supplementing
the growth media with oleic acid (OA) and subsequently stained
these cells with the neutral lipid dye BODIPY493/503 and with
anti-Irgm3 antibody. We found that Irgm3 co-localized with the
BODIPY dye in IFNc-treated MEFs (Figure 5A). To determine
whether additional IRGM proteins localize to LDs, we monitored
the localization of C-terminally V5-tagged Irgm1, Irgm2 and
Irgm3 inside OA-treated MEFs. In addition to Irgm3-V5, Irgm1-
V5 and Irgm2-V5 co-localized with a subset of LDs but not with
inclusions (Figure 5B and Figure S1). Staining for endogenous
protein confirmed the presence of Irgm1 but not Irgm2 on a subset
of LDs (Figure S2 and data not shown). We next asked if GKS
proteins were also found on LDs by immunostaining IFNc-
activated MEFs with antibodies directed against three represen-
tative GKS proteins Irga6, Irgb6 and Irgb10. We were unable to
detect co-localization of these proteins with BODIPY-labeled LDs
in wildtype MEFs by immunofluorescence (Figure 5C and D).
We independently confirmed these observations by assessing the
levels of IRG proteins on purified LDs. LDs purified from IFNc-
treated, wildtype MEFs by sucrose gradient centrifugation
displayed significant levels of Irgm1 and Irgm3 (Figure 5E), and
Figure 3. Irgm1 and Irgm3 are critical co-factors for targeting the GKS proteins Irgb10, Irga6 and Irgb6 to C. trachomatis inclusions.
MEFs were infected with C. trachomatis and media +/2 IFNc at 100 U/ml was replaced at 3 hpi. Cells were fixed at 20 hpi and stained with anti-C.
trachomatis and anti-GKS antibodies. The frequency of GKS-positive inclusions is shown in MEFs of the indicated genotypes. Graph represents
average values 6 SD. Data are representiaitve of three independent experiments. Statistical significance of group values relative to wildtype and
between marked groups are shown (*, p,0.05; **, p,0.01; and ***, p,0.005).
doi:10.1371/journal.ppat.1003414.g003
IRGM Proteins Guard Endomembranes
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Figure 4. T. gondii PVs and C. trachomatis inclusions are largely devoid of Irgm1/m3. Images and line tracing of fluorescent intensity are
shown. Data are representative of results obtained in at least 3 independent experiments conducted for each experimental design. (A). IFNc-
activated MEFs were infected with GFP-expressing T. gondii and stained with an anti-Irga6 and anti-Irgm3 antibody. (B) IFNc-activated MEFs were
infected with GFP-expressing C. trachomatis and stained with an anti-Irga6 and anti-Irgm3 antibody at 2 hpi. (C) MEFs were infected with C.
trachomatis and activated with 100 U/ml of IFNc at 3 hpi. Cells were fixed at 20 hpi and stained with an anti-Irga6 antibody in combinations with
either anti-Irgm1 or anti-Irgm3 antibodies and Hoechst. Whereas Irga6 co-localized with inclusions at the expected frequency of 10–15% (data not
shown), no targeting of endogenous Irgm1 or Irgm3 to inclusions was observed in the course of examining the staining of more than one hundred
randomly selected inclusions. Arrows point at inclusions.
doi:10.1371/journal.ppat.1003414.g004
IRGM Proteins Guard Endomembranes
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Figure 5. GKS proteins are enriched on LDs in IRGM-deficient cells. (A) Wildtype MEFs were treated overnight with OA and IFNc and
immunostained for endogenous Irgm3 and for LDs using BODIPY. (B) Wildtype MEFs were transfected with the three mouse paralogs Irgm1-3 tagged
with V5, infected with C. trachomatis and treated with OA and IFNc at 3 hpi. Cells were fixed at 20 hpi and stained with anti-V5, BODIPY and Hoechst.
White arrows point at inclusions. (C) The localization of the GKS proteins Irga6 and Irgb6 were visualized in wildtype and Irgm1/m32/2 MEFs treated
overnight with OA and IFNc. (D) Cells were treated overnight with OA and IFNc and stained with anti-Irgb10, BODIPY and Hoechst. Representative
images are shown. Overlap in fluorescence signals derived from anti-Irgb10 and BODIPY stains is shown for these representative images. Data were
analyzed as described in Materials and Methods and representative data of three independent experiments are shown. Statistical significance of
group values relative to wildtype and between marked groups is shown (***, p,0.005). (E) LDs and total cell lysate were obtained from wildtype,
Irgm1/m32/2 and Atg52/2 MEFs treated overnight with OA +/2 IFNc and analyzed by immunoblotting.
doi:10.1371/journal.ppat.1003414.g005
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relatively small amounts of Irgb10 (Figure 5E), suggesting possible
transient interactions between IRGM proteins and Irgb10 on the
surface of LDs. In summary, these data indicate that LDs of
wildtype cells are decorated with Irgm1 and Irgm3 but only
weakly associate with GKS proteins.
GKS proteins mislocalize to LDs in Irgm1/m32/2 cells
Although LDs could play an essential role in guiding GKS
proteins to inclusions, we thought this was unlikely, because LD-
deficient cells lines still target Irgb10 to inclusions (H.A.S. and
R.H.V., unpublished data). Because IRGM proteins inhibit GTP
acquisition by GKS proteins and are believed to thereby block the
ability of GKS proteins to bind lipids [15,16], we formed an
alternative hypothesis in which LD-resident IRGM proteins would
prevent GKS proteins from binding to LDs. To test our hypothesis,
we examined the localization of Irgb10 in Irgm1/m32/2MEFs that
contain IRGM-deficient LDs. We found that the LDs of Irgm1/
m32/2 MEFs were heavily decorated with Irgb10 (Figure 5D).
Targeting of Irgb10 to LD in Irgm1/m32/2 MEFs was primarily
due to the absence of Irgm3, because Irgm32/2 MEFs but not
Irgm12/2 MEFs displayed a substantial increase in the number of
Irgb10-positive LDs (Figure 5D). The simultaneous deletion of
both Irgm3 and Irgm1, however, exacerbated the association of
Irgb10 with LDs (Figure 5D) suggesting that these proteins fulfill
partially redundant functions in protecting LDs against Irgb10
targeting. The role of Irgm1 and Irgm3 in guarding LDs was not
limited to Irgb10 but extended to other GKS proteins including
Irga6 and Irgb6 (Figure 5C). Again, Irgm3 was predominantly
responsible for guarding LDs, because ectopic expression of
Irgm3 in either Irgm32/2 or Irgm1/m32/2 MEFs prevented
deposition of Irga6 on LDs (Figure S3). Irgm1 and Irgm3 were
also required to prevent Irgb10 accumulation on LD in primary
macrophages, indicating that the observed phenomenon is not
cell type specific (Figure S4). Furthermore, endogenous LDs
found infrequently in MEFs not treated with OA also acquired
Irgb10 in the absence of Irgm1 and Irgm3 (Figure S5A),
demonstrating that the aberrant localization of Irgb10 was not
induced by OA treatment. Lastly, consistent with our immuno-
fluorescence observations, we detected a robust increase in the
amount of Irgb10 protein present in the LD fraction derived from
Irgm1/m32/2 MEFs compared to wildtype MEFs (Figure 5E).
These data combined demonstrate that GKS proteins target LDs
in the absence of Irgm1/m3.
Because IRGM proteins can act as positive regulators of
autophagy [8,10,27], we also considered the possibility that the
mislocalization of GKS proteins to LDs in Irgm1/m32/2 cells was
a consequence of disrupted autophagy. To test this hypothesis, we
examined the subcellular localization of Irgb10 in autophagy-
deficient Atg52/2 MEFs. We did not observe an increase in the
association of Irgb10 protein with LDs in Atg52/2 MEFs
(Figure 5E and Figure S6), indicating that a defect in autophagy
is not the underlying cause for the mislocalization of GKS proteins
to LDs in Irgm1/m32/2 MEFs.
Next, we asked whether IRGM proteins exclusively guard LDs.
We observed that Irgb10 formed ‘‘aggregate-like structures’’ in
Irgm1/m32/2 cells that did not identify as LDs (Figure S5A),
suggesting that GKS protein could target additional ‘‘self’’
structures in the absence of Irgm1/m3. In support of this
hypothesis, we found that GKS proteins also targeted mitochon-
dria (Figure S5B) and peroxisomes (Figure S5C) in Irgm1/m32/2
cells. In wildtype cells mitochondria are decorated with Irgm1
(G.A.T., manuscript in preparation) and subsets of peroxisomes
stain positive for Irgm3 (Figure S5D). In summary, our data
suggest that IRGM proteins guard LDs and other organelles
against the stable association with GKS proteins.
A GTP-locked Irgb10 mutants targets IRGM-positive LDs
We demonstrated that endogenous GKS proteins like Irgb10
stably associate with LDs in the absence of IRGM proteins
(Figure 5). Similarly, ectopically expressed Irgb10 frequently
targets LDs in Irgm1/m32/2 MEFs (Figure S7A) but not in
wildtype MEFs (Figure 6A). Two distinct models could explain the
differential targeting of Irgb10 and other GKS proteins to IRGM-
deficient but not IRGM-positive LDs: in the first model, the
presence of IRGM proteins alters the molecular properties of LDs
such that LDs do not serve as binding substrates for GKS proteins;
in the second model, IRGM proteins directly interact with GKS
proteins on the surface of LDs and block lipid binding. Previous
studies have shown that IRGM proteins can transiently interact
with GKS proteins and thereby retain GKS proteins in the GDP-
Figure 6. A GTP-locked Irgb10 mutant targets Irgm3-positive LDs in wildtype MEFs. Wildtype MEFs were transfected with GFP-tagged
versions of Irgb10WT and Irgb10K81A. Cells were treated overnight with OA, infected with C. trachomatis and treated with IFNc at 3 hpi. At 20 hpi cells
were stained for (A) the LD marker Tip47 and DNA or (B) Irgm3 and DNA. Representative images are shown. Arrows point at Hoechst-stained
inclusions.
doi:10.1371/journal.ppat.1003414.g006
IRGM Proteins Guard Endomembranes
PLOS Pathogens | www.plospathogens.org 7 June 2013 | Volume 9 | Issue 6 | e1003414
bound, inactive state [15,16], thus supporting the second model.
We therefore predicted that an Irgb10 variant locked in the active,
GTP-bound state should be able to overcome IRGM protein
mediated restrictions on lipid binding and be able to target
IRGM-positive LDs. To generate a GTP-locked Irgb10 mutant,
we replaced the lysine residue of the conserved GKS motif with
alanine (Irgb10K81A), as homologous mutations in Irga6 or Irgb6
interfere with GTP hydrolysis and force these GTPases into a
GTP-locked state [16]. Similar to previous observations demon-
strating the targeting of GTP-locked Irga6 to T. gondii vacuoles
[16], we found that Irgb10K81A co-localized with C. trachomatis
inclusions (Figure 6). However, in contrast to Irgb10WT,
Irgb10K81A co-localized with Tip47-positive LDs (Figure 6A)
and Irgm3 (Figure 6B) in wildtype MEFs. In contrast to Irgb10WT
and Irgb10K81A, a mutant with low affinity binding for GTP
(Irgb10S82N) failed to associate with either inclusions or LDs
(Figure S7). Overall, these data are consistent with a model, in
which IRGM proteins on LDs block the activation of endogenous
Irgb10 on the surface of LDs and prevent their stable association
of Irgb10 with LDs.
GBP proteins target IRGM-deficient LDs
GBP proteins constitute a second large family of IFNc-inducible
GTPases known to target PVs and to provide resistance to
infections with vacuolar pathogens [3]. Because we previously
observed that the subcellular location of the GBP protein Gbp2 is
altered in the absence of IRGM proteins [27], we hypothesized
that IRGM proteins could guard self-membranes against the
improper deposition of not only GKS but also GBP proteins.
Consistent with this, we found that Gbp2 co-localized with LDs in
Irgm1/m32/2 but not in wildtype MEFs (Figure 7A) and was
enriched in LD fractions obtained from Irgm1/m32/2 cells
(Figure 7B). Irgm1 and Irgm3 appeared to fulfill partially
redundant functions in guarding LDs against Gbp2 targeting,
Figure 7. GBP proteins are enriched on IRGM-deficient LDs. MEFs of the indicated genotypes were treated overnight with OA alone or with
OA and IFNc. (A) MEFs were stained for endogenous Gbp2 and LDs using BODIPY (B) LDs and total cell lysate were obtained from wildtype, Irgm1/
m32/2 and Atg52/2 MEFs and analyzed by immunoblotting. Here, the same lysates and LD preparations were used as in Figure 5E. The data are
representative of three independent LD preparation experiments. (C) Quantitative analyses of Gbp2 co-localization with LDs were done using MBF-
ImageJ software as described in Materials and Methods. Data are representative of three independent experiments. Statistical significance of group
values relative to wildtype and between marked groups is shown (***, p,0.005). Corresponding representative images are shown in Figure S8. (D)
FLAG-tagged Gbp1WT and Gbp1K51A mutant were expressed in MEFs treated overnight with OA and IFNc. BODIPY and anti-FLAG staining was used to
monitor localization of Gbp1 to LDs.
doi:10.1371/journal.ppat.1003414.g007
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because Gbp2 localization to LDs was more pronounced in Irgm1/
m32/2 MEFs than in Irgm12/2 or Irgm32/2 single gene deletion
cells (Figure 7C and Figure S8). Because both Irgm1 and Irgm3
regulate the formation and/or maturation of autophagosomes
[8,27], it was formally possible that the mislocalization of Gbp2 to
LDs in Irgm1/m32/2 cells resulted from a defect of these cells in
autophagy. However, it is unlikely that defective autophagy is the
primary cause for mislocalization of Gbp2 to LDs, because LDs
inside autophagy-deficient Atg52/2 MEFs remained exempt from
Gbp2 targeting (Figure 7A and B).
Similar to endogenous Gbp2, we found that ectopically
expressed, N-terminally tagged FLAG-Gbp1 protein was redirect-
ed to LDs in the absence of Irgm1 and Irgm3 proteins (Figure 7D).
To determine whether activation of Gbp1 was critical for targeting
IRGM-deficient LDs, we expressed a FLAG-Gbp1K51A mutant
form that has previously been shown to be defective for nucleotide
binding and protein oligomerization [28]. In contrast to wildtype
FLAG-Gbp1, we found that FLAG-Gbp1K51A failed to associate
with LDs in Irgm1/m32/2 cells (Figure 7D). These data suggest
that the active form of Gbp1 associates with IRGM-deficient LDs.
The known Gbp1 effector p62 targets IRGM-deficient LDs
for degradation
Our data demonstrated that Gbp1 and Gbp2 localized to
IRGM-deficient LDs. One of the known effector molecules of
Gbp1 is the autophagic adaptor protein p62/sequestosome-1 [29].
We therefore hypothesized that Gbp1 proteins residing on IRGM-
deficient LDs would be able to recruit p62 to LDs. In support of
our hypothesis we found that 4–5% of LDs in IFNc-treated Irgm1/
m32/2 cells stained positive for p62 (Figure 8A). In contrast to
Figure 8. IRGM-deficient LDs recruit p62 and LC3-II. (A and B) Wildtype and Irgm1/m32/2 MEFs were treated overnight with OA and IFNc and
stained with BODIPY and anti-p62 or anti-LC3, respectively. Representative images of at least 3 independent experiments are shown. Where
indicated, cells were treated with Bafilomycin (BAF). (A, lower panel) Quantitative analyses of p62 co-localization with LDs were done using MBF-
ImageJ software as described in Materials and Methods (***, p,0.005). (C) Total cell lysates and LD protein preparations from the indicated samples
were analyzed for LC3 protein expression. Densitometric analyses for protein quantification were carried out using ImageJ 1.45 s software. The
relative optical density (O.D.) for LC3-II expression normalized against expression of the LD marker Tip47 is listed below the corresponding lanes in
arbitrary units.
doi:10.1371/journal.ppat.1003414.g008
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Irgm1/m32/2 cells, we were unable to detect p62 on LDs of IFNc-
treated wildtype cells using immunofluorescence microscopy
(Figure 8A).
A critical function of p62 is to bind to macromolecular cargo
that is destined for autophagic destruction [30]. To deliver its
cargo to autophagosomes, p62 also binds directly to the ubiquitin-
like protein LC3, a maker of autophagosomes. To determine
whether IRGM-deficient LDs are delivered to autophagosomes
upon IFNc activation, we incubated both wildtype and Irgm1/
m32/2 MEFs with OA and IFNc and subsequently stained cells
with anti-LC3 and BODIPY. In these experiments, we frequently
observed LDs that were engulfed within ring-like LC3-positive
structures in Irgm1/m32/2 but not in wildtype MEFs (Figure 8B).
Similarly, LDs purified from Irgm1/m32/2 cells were enriched for
LC3-II, the lipidated form of LC3 that is associated with
autophagosomes (Figure 8C). Collectively, these data strongly
suggested that IRGM-deficient LDs were captured inside
autophagosomes upon IFNc activation.
To test this model further, we treated cells with the lysosomo-
tropic H+-ATPase inhibitor bafilomcyicn (BAF), a known inhibitor
of autophagic flux [31]. We observed a substantial increase in the
number of p62-positive LDs in Irgm1/m32/2MEFs upon combined
treatment with IFNc and BAF (Figure 8A). BAF treatment also
resulted in the appearance of p62-positive LDs in IFNc-treated
wildtype MEFs, however, at a frequency significantly lower than
what we observed in BAF-treated Irgm1/m32/2MEFs (Figure 8A).
These data indicated that the targeting of p62 to IRGM-deficient
LDs resulted in the degradation of LD-bound p62. Furthermore,
our observations excluded an alternative model in which the
increase in the number of p62-positve LDs in Irgm1/m32/2 MEFs
was due to a defect in autophagosome maturation in these cells.
We then asked whether the increased association of p62 and
LC3 with IRGM-deficient LDs would affect the total mass of LDs.
To quantify LD mass, we used a flow cytometry approach using
BODIPY staining, as previously described [26]. We found that
IFNc treatment resulted in an increase in the BODIPY signal in
wildtype MEFs, similar to the observations previously made in
dendritic cells [26]. In contrast to the increase in the BODIPY
signal observed in IFNc-treated wildtype cells, the BODIPY signal
decreased in IFNc-treated Irgm1/m32/2 MEFs (Figure 9 and
Figure S9), suggesting increased rates of LD degradation in
IRGM-deficient cells. To determine whether the decrease in LD
mass in Irgm1/m32/2 MEFs was due to autophagy ( = lipophagy),
we treated cells with BAF. BAF treatment blocked the IFNc-
induced decrease in LD mass in Irgm1/m32/2MEFs (Figure 9). In
sum, these data strongly support a model in which p62 targets
IRGM-deficient but not IRGM-guarded LDs and delivers IRGM-
deficient LDs to autophagosomes for degradation.
IRGM proteins facilitate GBP protein targeting to C.
trachomatis inclusions and T. gondii PVs
It has previously been reported that targeting of GBP proteins to
T. gondii PVs is facilitated by unknown IFNc-inducible factors
[32,33]. Because our data had already established functional
interactions between GBP and IRGM proteins, we asked whether
IRGM proteins could act as IFNc-inducible co-factors promoting
the recruitment of Gbp2 to PVs. We found that ectopically
expressed Gbp2-GFP fusion proteins failed to localize to C.
trachomatis inclusions in the absence of IFNc treatment or in IFNc-
activated Irgm1/m32/2 cells (Figure 10A). Similarly, we observed
that both Irgm1 and Irgm3 played critical roles in facilitating
targeting of endogenous Gbp2 protein to inclusions (Figure 10B
and C). Similar to Gbp2, recruitment of FLAG-Gbp1 to inclusions
was also dependent on IRGM proteins (Figure 10D). To
determine whether the regulatory role of IRGM proteins extends
to the recruitment of GBP proteins to PVs formed by pathogens
other than C. trachomatis, we monitored co-localization of both
Gbp2 and, as a control, Irgb10 with T. gondii vacuoles in wildtype,
Irgm12/2, Irgm32/2 and Irgm1/m32/2 MEFs. We observed that
the deletion of both Irgm1 and Irgm3 caused a near complete defect
in the recruitment of Irgb10 (Figure 10E) and Gbp2 to T. gondii
PVs at 0.5 hpi (Figure 10F). These observations demonstrate that
the expression of IRGM proteins is critical for the efficient delivery
of GBP proteins to vacuoles formed by distinct intracellular
pathogens.
Figure 9. IFNc induces degradation of LDs in Irgm1/m32/2MEFs. Cells were cultured overnight in the absence or presence of IFNc and in the
absence of OA. 12 hours post IFNc treatment, BAF was added to the culture media as indicated for an additional 8–12 hours and the BODIPY signal
was measured by flow cyometry. Flow cytometry histograms of BODIPY-labeled wildtype and Irgm1/m32/2 MEFs representative of three
independent experiments are shown. The fold change in the average mean fluorescent intensity (MFI) in response to IFNc treatment is plotted in the
panel on the right (***, p,0.005).
doi:10.1371/journal.ppat.1003414.g009
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Figure 10. Irgm1 and Irgm3 are critical co-factors for the targeting of GBP proteins to C. trachomatis inclusions and T. gondii PVs. (A)
Localization of ectopically expressed GFP-Gbp2 was monitored in C. trachomatis infected MEFs at 20 hpi. Arrows point at Hoechst-stained inclusions
(B). Wildtype and Irgm1/m32/2 MEFs were infected with C. trachomatis, left untreated or treated with IFNc at 3 hpi. Cells were fixed at 20 hpi and
stained with anti-C. trachomatis, anti-Gbp2 and Hoechst. (C) Co-localization of Gbp2 with inclusions in wildtype and Irgm1/m32/2 MEFs was
quantified as described in Materials and Methods. Error bars represent standard deviations of three independent experiments. Statistical significance
of group values relative to wildtype and between marked groups is shown (*, p,0.05; **, p,0.01; and ***, p,0.005). (D) MEFs were transfected with
FLAG-Gbp1, infected with C. trachomatis and activated with IFNc at 3 hpi. Cells were fixed at 20 hpi and stained with anti-FLAG and anti-C.
trachomatis. Representative images are shown. (E) MEFs were treated overnight with 200 U/ml of IFNc prior to infections. Localization of endogenous
Irgb10 to T. gondii PVs was monitored at 0.5 hpi. Data are representative of three independent experiments (*, p,0.05 relative to wildtype). (F)
Localization of endogenous Gbp2 to T. gondii was monitored at 0.5 hpi. Data are representative of three independent experiments (*, p,0.05 relative
to wildtype). Representative epifluorescent images of T. gondii-infected wildtype and Irgm1/m32/2 MEFs are shown.
doi:10.1371/journal.ppat.1003414.g010
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Discussion
The data presented in this study support a model in which
Irgm1 and Irgm3 proteins act as ‘‘guard molecules’’ that block
GKS and GBP proteins from stably associating with ‘‘self’’
structures (Figure 11). On PVs, however, guarding Irgm1 and
Irgm3 proteins are present at such low levels that GKS and GBP
proteins can firmly attach to these unprotected membranes. In
support of our model we found that Irgm1 and Irgm3, but not
GKS and GBP proteins, are present in LDs of wild type cells
(Figure 5 and Figure 7). In the absence of Irgm1 and Irgm3,
however, normally GKS-/GBP-deficient LDs become decorated
with various GKS and GBP proteins. We provide evidence that
GKS and GBP proteins assemble on IRGM-deficient LDs in
their GTP-bound, i.e. ‘‘active’’ state (Figure 7 and Figure S7).
According to our model GKS-/GBP-decorated LDs should
resemble GKS-/GBP-decorated PVs and would therefore be
expected to become targets of GKS-/GBP-solicited immune
responses. Consistent with such a scenario, we demonstrate that
the Gbp1 effector protein p62 is recruited to IRGM-deficient
LDs. The targeting of p62 to LDs in Irgm1/m32/2 MEFs likely
accounts for the enhanced association of IRGM-deficient LDs
with the autophagic marker LC3-II and the decrease in LD mass
upon IFNc activation that we observed in Irgm1/m32/2 MEFs.
Our observations are consistent with a previous report that
showed that the number of LDs is significantly reduced in IFNc-
activated Irgm32/2 dendritic cells compared to IFNc-activated
wildtype dendritic cells [26]. Whereas the authors of this previous
study speculated that Irgm3 could play a role in the neoformation
of LDs triggered upon IFNc receptor signaling, our data strongly
suggest that the decrease in LDs observed in IRGM-deficient cells
primarily results from GBP-mediated autophagy of LDs. How-
ever, because our experiments were conducted in MEFs,
additional studies are needed to determine whether Irgm3 may
also play a role in LD neoformation in dendritic or other cell
types.
While we propose that IRGM proteins guard self-organelles
against misdirected attacks by GKS and GBP proteins, our studies
do not exclude additional roles for IRGM proteins in organelle
homeostasis. For example, human IRGM protein translocates to
mitochondria and induces mitochondrial fission [10]. Because
mitochondrial fission not only results in the production of radical
oxygen species and the induction of antimicrobial autophagy, but
also contributes to the isolation and removal of damaged segments
of mitochondria, IRGM proteins may indeed regulate the
homeostasis of specific organelles like mitochondria.
The question now arises as to why the ‘‘guarding’’ Irgm1 and
Irgm3 proteins are present on ‘‘self’’ membranes but largely absent
from ‘‘non-self’’ PVs. The answer to this question may be quite
obvious, if one considers that IRGM proteins can exert
antimicrobial activities directly, once localized to PVs [3]. To
escape from IRGM-mediated antimicrobial activities like lyso-
somal targeting, we propose that vacuolar pathogens have evolved
strategies to actively avoid co-localization with IRGM proteins.
The absence of Irgm1/m3 from PVs would initially allow
pathogens to establish a vacuolar niche permissive for microbial
replication. However, the evasion of IRGM proteins would
simultaneously mark PVs for immune targeting by GKS and
GBP proteins. The principle underlying this type of intracellular
immune recognition is similar to the extracellular immune
recognition process by which NK cells detect transformed and/
or virus-infected cells [34]. NK cells express inhibitory receptors
on their cell surface. The ligands for one set of inhibitory NK
receptors are MHC class I molecules displayed on the surface of
host cells. The primary function of the MHC class I molecules is to
display viral or tumor antigens to cytotoxic T cells. To avoid
immune recognition by cytotoxic T cells, many tumor cells and
viruses have evolved mechanisms to downmodulate MHC class I
Figure 11. Proposed model: IRGM proteins regulate the localization of GKS and GBP proteins away from ‘‘self’’ membranes and
towards ‘‘non-self’’ PVs. Upon GTP acquisition ( = ‘‘activation’’), GKS and GBP proteins transition into a conformational state that permits lipid
binding. Protein oligomerization of activated GKS and GBP proteins further increases their membrane-binding activity and is critical for the stable
association of GKS and GBP proteins with most membranes. IRGM proteins negatively regulate the ‘‘activation’’ and subsequent oligomerization of
GKS and GBP proteins. Accordingly, IRGM-positive membranes/micelles (e.g. LDs) are protected against GKS and GBP binding and IRGM-free
membranes (e.g. surrounding PVs) are targets for GKS and GBP binding. In addition to protecting self-structures, IRGM proteins also maintain a pool
of inactive, monomeric GKS and GBP proteins. Monomeric GKS and GBP proteins are cytosolic and move around inside the cell until they encounter
PVs. In Irgm1/m32/2 cells, the binding to IRGM-deficient endomembranes decreases the pool of available, monomeric GKS and GBP proteins and
therefore diminishes the targeting of GKS and GBP proteins to PVs. In this illustration, the GKS protein Irgb10 with its two the putative lipid binding
domains is given as an example (Myr =myristoyl group; aK= amphipathic helix).
doi:10.1371/journal.ppat.1003414.g011
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surface expression. However, the failure of MHC class I-deficient
cells to provide an inhibitory signal to NK cells, allows NK cells to
recognize the missing of ‘‘self’’ MHC class I in transformed or
infected cells. In this analogy IRGM proteins resemble MHC class
I molecules: just like MHC class I molecules, IRGM proteins fulfill
dual functions in that they can promote antimicrobial activities
directly and simultaneously act as inhibitory molecules that block
the activation of an alternative defense system.
How do Irgm1 and Irgm3 proteins guard membranes against
GKS and GBP proteins? Studies performed by Howard and
colleagues indicate that IRGM proteins act as Guanine nucleotide
Dissociation Inhibitors (GDI) for GKS proteins [15,16]. Based on
these findings, Howard and colleagues proposed that by main-
taining GKS GTPases in the GDP-bound, monomeric state,
IRGM proteins reduce the lipid binding capacity of GKS proteins
and block their stable association with IRGM-coated membranes.
Here, we provide direct evidence in support of this model. As
originally proposed by Hunn et al., our data indicate that the
absence of IRGM proteins from PVs promotes the transition of
GKS proteins into the GTP-bound, active state and their stable
association with IRGM-deficient PVs. We show here that IRGM-
deficient membranes are also targets for GBP proteins (Figure 7).
Whether IRGM proteins act as GDIs for GBP proteins or block
the ability of GBP proteins to associate with LDs by an alternative
mechanism will need to be elucidated in future studies.
The lipid binding substrates for GKS and GBP proteins are
currently unknown. However, lipid components that are present in
LDs as well as in T. gondii parasitophorous and Chlamydia inclusion
membranes are obvious candidates to act as GKS- and GBP-
interacting molecules. It is tempting to speculate that GKS and
GBP proteins might have evolved to preferentially bind to lipids
that are frequently found in PVs but infrequently found on the
cytosolic face of most endomembranes [35]. According to this
model, most ‘‘self’’ structures would be protected against the
erroneous attack by GKS and GBP proteins for two reasons: 1) the
presence of guarding IRGM proteins and 2) the relative sparsity of
lipid binding substrates on the cytosolic leaflet of ‘‘self’’-
membranes. This model would suggest that GKS and GBP
proteins tether specifically to PVs due to the missing of ‘‘self’’
IRGM proteins from PVs and the presence of an unknown
‘‘second signal’’ on PVs. As suggested above, a unique pattern of
lipids may provide such a second signal, although other molecules
may also be involved. Albeit speculative at this point, we propose
that LDs feature such a second signal and therefore become
primary targets for GKS and GBP proteins in the absence of
IRGM guard molecules.
The requirement of a second signal for GKS/GBP membrane
targeting as proposed in the model outlined above could in part
explain why Irgm1/m32/2 mice and cells are viable in spite of
lacking two critical ‘‘guard’’ proteins. Alternatively, expression of
Irgm2 in Irgm1/m32/2 cells may provide sufficient protection to
assure survival of Irgm1/m32/2 cells upon immune activation.
This second model would necessitate that Irgm2 like Irgm1/m3
guards ‘‘self’’ membranes against GKS and GBP proteins.
In addition to guarding self-structures, expression of IRGM
proteins is required for the efficient targeting of endogenous GKS
proteins to C. trachomatis inclusions (Figure 3) and T. gondii PVs
[16]. However, tetramerized Irgb10-dsRED, when overexpressed,
targets PVs efficiently in IRGM-deficient cells (Figure 2A). These
data argue against a direct role for IRGM proteins in delivering
GKS proteins to PVs. We therefore propose a model in which
IRGM proteins fulfill an indirect role in targeting endogenous
GKS proteins to PVs: in this model GKS proteins can bind to an
excess of unguarded ‘‘self’’ membranes in IRGM-deficient cells.
Consequently, the cellular pool of available GKS proteins is
diminished in IRGM-deficient cells and the efficiency of PV
targeting is reduced.
In addition to GKS proteins, GBP proteins also bind to PVs.
The delivery of GBP proteins to PVs requires the presence of a
previously unknown IFN-inducible cofactor(s) [32,33]. Here, we
identify IRGM proteins as one such co-factor. We propose that
IRGM proteins promote the recruitment of GBP proteins to PVs
by a mechanism similar to that which regulates the subcellular
localization of GKS proteins. GBP proteins bind to lipids as
activated oligomers [36,37] and GBP mutants deficient in GTP
binding fail to localize to PVs [29,33]. In this study, we
demonstrate that IRGM proteins on LDs prevent GBP recruit-
ment, suggesting that IRGM proteins interfere with the ability of
GBP proteins to transition into the GTP-bound, oligomeric state.
In support of this hypothesis, we found that Gbp2 forms high
molecular weight aggregates in the absence of Irgm1/m3 (A.S.P.
and J.C., unpublished results). Therefore, IRGM proteins may
promote GBP recruitment to PVs by maintaining a pool of GDP-
bound, monomeric GBP proteins that are able to diffuse to their
target sites.
Additional evidence for functional interactions between the
GBP and IRG protein families comes from the observation that
one or more members of GBP protein family associate with Irgb6
in complexes [38]. Deletion of the chromosomal region containing
the genes Gbp1-3, Gbp5 and Gbp7 causes a partial defect in the
recruitment of Irgb6 and Irgb10 but not Irga6 to T. gondii PVs
[38], suggesting that physical interactions between specific GBP
proteins and Irgb6/b10 promote targeting of Irgb6/b10 to PVs. In
contrast to the partial GKS targeting defects of Gbp-deficient cells,
Irgm1/m32/2 cells display a nearly complete deficiency in
recruiting either Irgb10 (Figure 10E) or Gbp2 protein to T. gondii
PVs (Figure 10F). The combined results from both studies suggest
that Irgm1 and Irgm3 regulate the recruitment of both GKS and
GBP proteins to PVs, while one or more PV-targeted GBP
proteins augment the recruitment of a subset of GKS proteins
through direct physical interactions. In summary our data
demonstrate that IRGM proteins orchestrate the proper targeting
of antimicrobial GBP and GKS proteins away from ‘‘self’’
membranes and towards ‘‘non-self’’ PVs.
Materials and Methods
Host cell culture, bacterial and protozoan strains and
infections
MEFs derived from wildtype, Irgm12/2, Irgm32/2 and Irgm1/
m32/2 mice were previously described [39,40]. MEFs and African
green monkey kidney Vero cells were cultured in Dulbecco’s
modified Eagle’s medium supplemented with 10% heat-inactivat-
ed fetal bovine serum (FBS) (Denville and Life Technologies).
Primary murine bone marrow macrophages were isolated from
the tibia and femurs of 2- to 4-months-old mice as described before
[41]. C. trachomatis LGV-L2 was propagated as described [39]. A
previously described GFP-expression vector [42] was introduced
into LGV-L2 for visualizing C. trachomatis at 2 hpi. GFP-expressing
Toxoplasma gondii tachyzoites of the type II strain Prugniaud A7
were a generous gift from Dr. John Boothroyd (Stanford
University, Stanford, CA) [43]. Infections with C. trachomatis were
performed at a nominal multiplicity of infection of 1–5 as
described [39]. For T. gondii infections cells were incubated
overnight with or without 200 U/ml of IFNc and asynchronously
infected with tachyzoites at a nominal multiplicity of infection of
5–10 for thirty minutes.
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Induction of LD formation, LD purification and
immunoblotting
For lipid loading experiments, OA (Sigma) was precomplexed
with fatty acid-free BSA (Sigma) in PBS and emulsified by
sonication. OA was added to growth media at final concentration
of 100 mM for immunofluorescence experiments. LDs were
isolated from MEFs as described before [44] with minor
modifications as outlined here. Cells were grown in 150 mm
dishes in DMEM +10% FBS and incubated with OA at 300 mM
in the presence or absence of 100 U/mL of IFNc for 14 h before
harvesting LDs. Cells were washed with PBS and collected in 5 ml
TNE buffer [20 mMTris-HCl (pH 7.5), 0.15 M NaCl, and 1 mM
EDTA] containing protease inhibitors (Roche Diagnostics). Cells
were lysed on ice with ,30 strokes/150 mm dish in a Dounce
homogenizer and 80 ml of total lysates were collected from each
sample and stored at 220uC for Western blotting. Cell lysates
were then adjusted to 0.45 M sucrose, overlaid with 2 ml each of
0.25 M, 0.15 M, and 0 M Sucrose/TNE and centrifuged at
30,000 rpm for 90 min at 4uC in an SW41 rotor (Beckman
Coulter). The floating LD-enriched fat layer was collected, diluted
in TNE, and refloated at 47,000 rpm for 45 min in a TLA55 rotor
(Beckman Coulter). LDs were collected, and lipids were extracted
with 4 volumes of diethyl ether. Delipidated proteins were
precipitated with ice-cold acetone for 1 h, solubilized in
0.1%SDS and 0.1 N NaOH, and normalized for total protein
content by Bradford assay before SDS-PAGE and immunoblot
analysis. Following protein transfer to nitrocellulose membranes,
membranes were incubated with antibodies as listed below.
Densitometric analyses for protein quantification in Western blots
were carried out using Image J 1.45 s software.
Immunocytochemistry, BODIPY staining and data
analysis
Immunocytochemistry was performed essentially as described
previously [39,44]. Cells were washed thrice with PBS, pH 7.4
prior to fixation. Cells were fixed with 3% formaldehyde and
0.025% glutaraldehyde for 20 min at room temperature (RT) in
all experiments that visualized LDs. T. gondii-infected cells were
fixed with 4% paraformaldehyde in PBS, pH 7.4, cells for 20 min
at RT. In all experiments involving LD staining, fixed cells were
permeabilized/blocked with 0.05% (v/v) saponin and 2% BSA/
PBS (SBP) for 30 min at RT. When preserving LD structures was
not required, fixed cells were permeabilized in 0.1% (v/v) Triton
X-100 in PBS for ten minutes, blocked for 1 h with 2% (w/v) BSA
(Equitech-Bio Inc.) in PBS, and then stained with various primary
antibodies, followed by Alexa Fluor-conjugated secondary anti-
bodies (Molecular Probes/Invitrogen). Working solutions of
antibodies and BODIPY 493/503 (10 mg/ml) (Invitrogen) for
immunofluorescence were prepared in SBP (for LD visualization)
or in 2% (w/v) BSA/PBS (for all other experiments). Nucleic and
bacterial DNA were stained with Hoechst 33258 according to the
manufacturer’s protocol. Mitochondria were visualized using
MitoTracker Red CMXRos (Invitrogen) according to the man-
ufacturer’s instructions. Stained cells were washed with PBS,
mounted on microscope slides with FluorSave (Calbiochem) or
ProLong Gold (Invitrogen), and allowed to cure overnight. Cells
were imaged using either a Zeiss LSM 510 inverted confocal
microscope or a Zeiss Axioskop 2 upright epifluorescence
microscope. Co-localization of proteins with PVs was quantified
in at least 3 independent experiments. In each experiment at least
ten randomly selected fields were imaged for each condition for
each cell type. Differential interference contrast images were used
to identify extracellular T. gondii tachyzoites because the vacuoles
typically contained only one parasite under the experimental
conditions used. The fraction of Gbp2- or Irgb10-positive vacuoles
was determined for each field by dividing the number of Gbp2- or
Irgb10-labeled vacuoles by the total number of vacuoles. Co-
localization with C. trachomatis inclusions was quantified using the
identical approach. Co-localization of Irgb10 and Gbp2 with LDs
was quantified using MBF ImageJ software (developed by Wayne
Rasband, National Institutes of Health, Bethesda, MD; available
at http://rsb.info.nih.gov/ij/index.html). Images were pre-pro-
cessed to correct uneven illumination and to minimize noise and
background. The co-localization rates were measured based on
Manders’ coefficient, which varies from 0 to 1. A coefficient value
of zero corresponds to non-overlapping images while a value of 1
reflects 100% co-localization between the images being analyzed.
To perform line tracings, i.e. analyze the fluorescence signal
intensity profiles of pixels along a selection from images, we used
ImageJ software.
LDs measurement by flow cytometry
Cells were treated with or without IFNc (200 U/ml) in the
absence or presence of OA for 20 to 24 hours. Where indicated,
BAF was supplemented at a final concentration of 100 nM at
12 hours post IFNc activation. LD mass was determined by Flow
Cytometry as described elsewhere [26]. Briefly, after fixing the
cells with 2% PFA, cells were stained with BODIPY 493/503 at
5 mg/ml in FACS buffer (PBS, 1% BSA and 0.1% NaN3) for
30 minutes and washed with FACS buffer prior to analysis.
Antibodies
The primary antibodies used included anti-Irgm1 mouse
monoclonal antibody 1B2 [11] at 1:10; anti-Irga6 mouse
monoclonal antibody 10D7 [12] at 1:10; anti-Irgb10 rabbit
polyclonal antiserum [39] at 1:1000; anti-Irgb6 rabbit polyclonal
antisera [27] at 1:1000; anti-Irgm3 rabbit polyclonal antisera [45]
at 1:1000; mouse monoclonal anti-Irgm3 antibody (BD-Trans-
duction Labs) at 1:300; FITC-labeled mouse monoclonal anti-C.
trachomatis MOMP [39] at 1:200; rabbit anti-IncG [46] at 1:50;
anti-V5 mouse monoclonal antibody (Invitrogen) at 1:1000; anti-
FLAG mouse monoclonal antibody F1804 (Sigma) at 1:500, rabbit
anti-Pmp70 (abcam) at 1:500; anti-TIP47 polyclonal antisera
(Proteintech) at 1:1000; anti-p62/SQSTM1 rabbit polyclonal
antibody (MBL International) at 1:500; and anti-LC3 rabbit
polyclonal antibody (MBL International) at 1:1000. An affinity-
purified polyclonal rabbit anti-Gbp2 antibody was generated
against the peptide EVNGKPVTSDEYLEHS of Gbp2 and used
at 1:1000.
Cloning of expression constructs and cell transfection
An Irgb10-GFP expression construct has been previously
described [39]. Site-directed mutagenesis was performed using
the QuikChange II Site-Directed Mutagenesis Kit (Agilent
Technologies Inc.) to introduce the listed point mutations and
deletions into the same construct. Standard cloning techniques
were used to generate to insert DNA encoding dsRED and the
yeast protein TyA into the listed GFP expression constructs. DNA
oligonucleotides used for cloning are listed in Table 1. A
previously described TyA expression construct [21], a kind gift
from Dr. Stephen Gould, was used as a template for DNA
amplification. The C57BL/6J-derived cDNAs of Irgm1, Irgm2
and Irgm3 were cloned into pcDNA3.1/V5-His-TOPO (Invitro-
gen) following the manufacturer’s instructions. FLAG-tagged and
GFP-tagged expression constructs of Gbp1 and Gbp2 and Gbp1
mutant variants have been previously described [33]. MEFs were
transduced using the MSCV-based delivery system (Clontech) or
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transfected using Attractene (Qiagen) following the manufacturers’
instructions.
Statistical analysis
Results are represented as means 6 SD. All comparisons were
evaluated for statistical significance through the use of unpaired
two-tailed t tests. When necessary, significant differences between
data points were highlighted and the level of significance was
depicted as: *, p,0.05; **, p,0.01; and ***, p,0.005.
Supporting Information
Figure S1 Ectopically expressed V5-tagged IRGM pro-
teins localize to LDs. Wildtype MEFs were transfected with
expression plasmids for V5-tagged Irgm1, Irgm2 and Irgm3 and
treated overnight with OA and IFNc. Cells were fixed and stained
with anti-V5 and BODIPY. Overlap between fluorescent anti-V5
and BODIPY staining of representative images is shown.
(TIF)
Figure S2 Endogenous Irgm1 localizes to LDs. Wildtype
MEFs were treated overnight with OA+/2IFNc. Cells were
stained for endogenous Irgm1 and LDs using BODIPY. Whereas
we detected endogenous Irgm1 on LDs, we failed to detect
endogenous Irgm2 on LDs using three distinct antibodies (data not
shown).
(TIF)
Figure S3 Ectopic expression of Irgm3 in Irgm3-deficient
cells dissolves aggregate staining of Irga6 in OA-treated
cells. Irgm32/2 and Irgm1/m32/2 MEFs were transduced with a
retroviral expression vector for Irgm3 (pIrgm3) or an empty vector
control (pBABE) and treated with OA and IFNc. Expression of
Irgm3 abolished the droplet-like staining pattern of Irga6 in both
Irgm32/2 and Irgm1/m32/2 MEFs.
(TIF)
Figure S4 Irgb10 protein is enriched on IRGM-deficient
LDs in macrophages. Primary bone marrow-derived maro-
phages of the indicated genotypes were stained with BODIPY and
anti-Irgb10 after overnight treatment with OA and IFNc.
Quantitative analyses of Irgb10 co-localization with LDs were
performed using MBF-ImageJ software as described in Materials
and Methods. Data are the representative of three independent
experiments. Statistical significance of group values relative to
wildtype and between marked groups is shown (***, p,0.005).
Representative images are shown.
(TIF)
Figure S5 GKS proteins mislocalize to endogenous LDs
and peroxisomes in Irgm1/m32/2. (A) Irgb10 localizes to
LD in the absence of OA in Irgm1/m32/2 MEFs. We observed
additional aggregate-like, Irgb10-positive structures that did not
stain with BODIPY. (B) A subset of these structures stained
positive with MitoTracker Red. (C) Similar to rabbit anti-Irgb10,
mouse anti-Irga6 antibody stained aggregate-like structures in
Irgm1/m32/2 but not wildtype cells. Whereas some of these
structures stained positive for BODIPY (data not shown), a subset
of these structures were decorated with peroxisome marker
Pmp70 stained with rabbit anti-Pmp70. (D) A subset of
peroxisomes stained positive for mouse anti-irgm3 in wildtype
cells.
(TIF)
Figure S6 Irgb10 protein is absent from LDs in Atg52/
2 MEFs. Atg52/2 MEFs incubated with and without OA and
IFNc were stained for Irgb10 and LDs (BODIPY).
(TIF)
Figure S7 An Irgb10 mutant (S82N) deficient for GTP
binding fails to localize to LDs. Irgm1/m32/2 MEFs were
transfected with (A) Irgb10WT or (B) Irgb10S82N fused to GFP.
Cells were treated overnight with OA and IFNc and stained for
the LD resident protein Tip47 and DNA (Hoechst). White arrows
point at inclusions. Wildtype Irgb10 but not Irgb10S82N targets
both inclusion and IRGM-deficient LDs. Representative images
are shown.
(TIF)
Figure S8 GBP proteins are enriched on IRGM-deficient
LDs. MEFs of the indicated genotypes were treated overnight
with OA and IFNc. Cells were stained for endogenous Gbp2, LDs
(BODIPY) and DNA (Hoechst). Representative images are shown.
Colocalization analyses of Gbp2 with LDs were done using MBF
ImageJ software as described in Materials and Methods.
(TIF)
Figure S9 IFNc activation results in a decrease in LD
mass as assessed by BODIPY staining in IRGM-
deficient MEFs. Wildtype and Irgm1/m32/2 MEFs were
treated with OA to enrich for total LD mass. Cells were treated
with IFNc and stained with BODIPY. Flow cytometry was used
to measure the BODIPY signal, which corresponds with LD
mass. The fold change in the average mean fluorescent intensity
(MFI) in response to IFNc treatment is plotted in the panel on the
right.
(TIF)
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